Prudential Financial Inc Acadia Pharmaceuticals Inc Transaction History

Prudential Financial Inc

$65.9 Billion
Q2 2024

A detailed history of Prudential Financial Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Prudential Financial Inc holds 35,811 shares of ACAD stock, worth $554,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,811

Previous 1,072,731 96.66%

Holding current value

$554,354

Previous $19.8 Million 97.07%

% of portfolio

0.0%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $15.2 Million - $19.1 Million	-1,036,920 Reduced 96.66%	35,811 $581,000
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $11.2 Million - $19.4 Million	629,615 Added 142.09%	1,072,731 $19.8 Million
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $2.4 Million - $3.67 Million	115,500 Added 35.25%	443,116 $13.9 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $3.51 Million - $5.63 Million	168,190 Added 105.5%	327,616 $6.83 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $2.12 Million - $3.06 Million	119,200 Added 296.33%	159,426 $3.82 Million
Q1 2023 May 12, 2023	BUY	$16.32 - $20.92 $656,488 - $841,527	40,226 New	40,226 $757,000
Q3 2022 Nov 04, 2022	SELL	$14.11 - $18.27 $128,894 - $166,896	-9,135 Reduced 34.56%	17,296 $283,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $35,127 - $73,494	2,700 Added 11.38%	26,431 $373,000
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $290,249 - $381,177	13,861 Added 140.44%	23,731 $575,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $9,906 - $15,983	-590 Reduced 5.64%	9,870 $230,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $4,891 - $7,678	310 Added 3.05%	10,460 $174,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $196,910 - $278,313	10,150 New	10,150 $248,000
Q1 2021 May 12, 2021	SELL	$25.02 - $54.99 $1.4 Million - $3.08 Million	-56,075 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $2.3 Million - $3.18 Million	56,075 New	56,075 $3 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $7,793 - $12,198	-214 Closed	0 $0
Q2 2020 Aug 05, 2021	SELL	$39.26 - $52.73 $4.83 Million - $6.48 Million	-122,926 Reduced 99.83%	214 $10,000
Q2 2020 Aug 12, 2020	BUY	$39.26 - $52.73 $4.83 Million - $6.48 Million	122,981 Added 77346.54%	123,140 $0
Q1 2020 Aug 05, 2021	SELL	$31.65 - $46.87 $9.48 Million - $14 Million	-299,473 Reduced 99.95%	159 $7,000
Q1 2020 May 12, 2020	BUY	$31.65 - $46.87 $9.48 Million - $14 Million	299,474 Added 189540.52%	299,632 $0
Q4 2019 Aug 05, 2021	SELL	$36.21 - $51.4 $14.8 Million - $21 Million	-407,605 Reduced 99.96%	158 $7,000
Q4 2019 Feb 11, 2020	BUY	$36.21 - $51.4 $14.8 Million - $21 Million	407,605 Added 257977.84%	407,763 $0
Q3 2019 Aug 05, 2021	SELL	$22.22 - $44.01 $8.75 Million - $17.3 Million	-393,866 Reduced 99.96%	158 $6,000
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $3.98 Million - $7.89 Million	179,220 Added 83.43%	394,024 $0
Q2 2019 Aug 08, 2019	BUY	$23.32 - $28.12 $3.91 Million - $4.72 Million	167,730 Added 356.31%	214,804 $0
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $559,886 - $948,032	34,625 Added 278.13%	47,074 $0
Q4 2018 Feb 07, 2019	BUY	$14.32 - $22.92 $13,589 - $21,751	949 Added 8.25%	12,449 $0
Q3 2018 Nov 07, 2018	SELL	$13.03 - $21.81 $1,824 - $3,053	-140 Reduced 1.2%	11,500 $0
Q2 2018 Aug 13, 2018	SELL	$15.07 - $22.34 $1.69 Million - $2.5 Million	-111,920 Reduced 90.58%	11,640 $0
Q1 2018 May 04, 2018	SELL	$22.47 - $32.33 $2.49 Million - $3.58 Million	-110,700 Reduced 47.26%	123,560 $0
Q4 2017 Feb 13, 2018	BUY	$26.84 - $39.14 $1.61 Million - $2.34 Million	59,799 Added 34.28%	234,260 $7.3 Million
Q3 2017 Nov 30, 2017	BUY	$29.49 - $38.37 $5.14 Million - $6.69 Million	174,461	174,461 $6.57 Million

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.51B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Acadia Pharmaceuticals Inc Transaction History